Mortality in gastric cancer patients treated with gastrectomy.
Two clinical series that assessed outcome of gastric cancer treated with gastrectomy and extended lymphadenectomy were reviewed using standard insurance medicine mortality abstract methods. The results were not conclusive; although they did suggest that extended level 2 (D2) lymphadenectomy may produce better long-term mortality outcomes than less extensive surgery in some circumstances.
Credit Suisse Life Insurance Co Ltd, Hongo MK Bldg, Hongo Bunkyo-ku, Tokyo, Japan. yasushi.iwasa@cslife.co.jp
Yasushi
Y
Iwasa
D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D005743:Gastrectomy; D006801:Humans; D007352:Insurance, Life; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D013274:Stomach Neoplasms / Q000191:economics / Q000401:mortality* / Q000601:surgery; D016019:Survival Analysis